Cargando…

Application of computed tomography-based radiomics in differential diagnosis of adenocarcinoma and squamous cell carcinoma at the esophagogastric junction

BACKGROUND: The biological behavior of carcinoma of the esophagogastric junction (CEGJ) is different from that of gastric or esophageal cancer. Differentiating squamous cell carcinoma of the esophagogastric junction (SCCEG) from adenocarcinoma of the esophagogastric junction (AEG) can indicate Siewe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Ke-Pu, Huang, Wen-Peng, Liu, Si-Yun, Chen, Yun-Jin, Li, Li-Ming, Liu, Xiao-Nan, Han, Yi-Jing, Zhou, Yue, Liu, Chen-Chen, Gao, Jian-Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453771/ https://www.ncbi.nlm.nih.gov/pubmed/36159013 http://dx.doi.org/10.3748/wjg.v28.i31.4363

Ejemplares similares

Surgical resection of gastric stump cancer following proximal gastrectomy for adenocarcinoma of the esophagogastric junction
por: Ma, Fu-Hai, et al.
Publicado: (2019)

Changes in the esophagogastric junction outflow obstruction manometric feature based on the Chicago Classification updates
por: Li, Yue-Yuan, et al.
Publicado: (2022)

Thoracoscopic esophagectomy is related to better outcomes in early adenocarcinoma of esophagogastric junction tumors
por: Takeda, Flavio Roberto, et al.
Publicado: (2021)

Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma
por: Yang, Bo, et al.
Publicado: (2018)

Surgical resection of esophagogastric junction stromal tumor: How to protect the cardiac function
por: Zheng, Guo-Liang, et al.
Publicado: (2021)

Integrative proteomic characterization of adenocarcinoma of esophagogastric junction
por: Li, Shengli, et al.
Publicado: (2023)

Priority of lymph node dissection for advanced esophagogastric junction adenocarcinoma with the tumor center located below the esophagogastric junction
por: Cai, Ming-Zhi, et al.
Publicado: (2019)

Clinical-radiomics nomogram for predicting esophagogastric variceal bleeding risk noninvasively in patients with cirrhosis
por: Luo, Rui, et al.
Publicado: (2023)

Model established based on blood markers predicts overall survival in patients after radical resection of types II and III adenocarcinoma of the esophagogastric junction
por: Wei, Zhi-Jian, et al.
Publicado: (2022)

Predictors of difficult endoscopic resection of submucosal tumors originating from the muscularis propria layer at the esophagogastric junction
por: Wang, Yu-Ping, et al.
Publicado: (2022)

Investigation of BTLA tagging variants with risk of esophagogastric junction adenocarcinoma
por: Tang, Weifeng, et al.
Publicado: (2019)

Laparoscopic-assisted vs open transhiatal gastrectomy for Siewert type II adenocarcinoma of the esophagogastric junction: A retrospective cohort study
por: Song, Qi-Ying, et al.
Publicado: (2022)

Radiomics model for distinguishing tuberculosis and lung cancer on computed tomography scans
por: Cui, E-Nuo, et al.
Publicado: (2020)

Association of anastomotic leakage with long-term oncologic outcomes of patients with esophagogastric junction cancer
por: Takeuchi, Masashi, et al.
Publicado: (2022)

Prediction of microvascular invasion in solitary hepatocellular carcinoma ≤ 5 cm based on computed tomography radiomics
por: Liu, Peng, et al.
Publicado: (2021)

Potential Value of Radiomics in the Identification of Stage T3 and T4a Esophagogastric Junction Adenocarcinoma Based on Contrast-Enhanced CT Images
por: Chang, Xu, et al.
Publicado: (2021)

Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma
por: Deng, Peng-Zhan, et al.
Publicado: (2022)

Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma
por: Niu, Xiang-Ke, et al.
Publicado: (2021)

Enhanced CT-based radiomics predicts pathological complete response after neoadjuvant chemotherapy for advanced adenocarcinoma of the esophagogastric junction: a two-center study
por: Huang, Wenpeng, et al.
Publicado: (2022)

Optimal treatment for Siewert type II and III adenocarcinoma of the esophagogastric junction: A retrospective cohort study with long-term follow-up
por: Hosoda, Kei, et al.
Publicado: (2017)

Radiomics model based on contrast-enhanced computed tomography to predict early recurrence in patients with hepatocellular carcinoma after radical resection
por: Li, Shu-Qun, et al.
Publicado: (2023)

Patterns of recurrence in adenocarcinoma of the esophagogastric junction: a retrospective study
por: Xu, Haitao, et al.
Publicado: (2020)

Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2018)

Quantitative parameters in novel spectral computed tomography: Assessment of Ki-67 expression in patients with gastric adenocarcinoma
por: Mao, Li-Ting, et al.
Publicado: (2023)

Current surgical treatment of esophagogastric junction adenocarcinoma
por: Zhang, Shun, et al.
Publicado: (2019)

Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction
por: Zhou, Zhangjian, et al.
Publicado: (2015)

Role of Nampt and Visceral Adiposity in Esophagogastric Junction Adenocarcinoma
por: Li, Haijun, et al.
Publicado: (2017)

The Value of Predicting Human Epidermal Growth Factor Receptor 2 Status in Adenocarcinoma of the Esophagogastric Junction on CT-Based Radiomics Nomogram
por: Wang, Shuxing, et al.
Publicado: (2021)

The Early Diagnostic Value of Serum Interleukin-8 in Esophagogastric Junction Adenocarcinoma
por: Li, Zheng, et al.
Publicado: (2021)

SIRGs score may be a predictor of prognosis and immunotherapy response for esophagogastric junction adenocarcinoma
por: OuYang, Li-Ying, et al.
Publicado: (2022)

Analysis of N(6)-Methyladenosine Methylome in Adenocarcinoma of Esophagogastric Junction
por: Huang, Jia-Bin, et al.
Publicado: (2022)

Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2019)

Gross tumor volume of adenocarcinoma of esophagogastric junction corresponding to cT and cN stages measured with computed tomography to quantitatively determine resectabiliy: A case control study
por: Li, Ke-ying, et al.
Publicado: (2022)

Surgical principles for optimal treatment of esophagogastric junction adenocarcinoma
por: Nobel, Tamar, et al.
Publicado: (2019)

Esophagogastric junction adenocarcinoma: Preoperative chemoradiation or perioperative chemotherapy?
por: Laxague, Francisco, et al.
Publicado: (2021)

Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction
por: Wang, Wen-Ping, et al.
Publicado: (2012)

Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction
por: Sun, Lidan, et al.
Publicado: (2014)

Changes of Quality of Life after Gastric Tube Reconstruction in Adenocarcinoma of the Esophagogastric Junction
por: Shen, Chaoyong, et al.
Publicado: (2013)

Role of dynamic computed tomography scans in patients with congenital craniovertebral junction malformations
por: da Silva, Otávio Turolo, et al.
Publicado: (2017)

Treatment Options for T1 Stage Adenocarcinoma of Esophagogastric Junction: A Real-World Retrospective Cohort Study
por: Zhou, Xiaoying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4ter6dm0af8tpg4lrjtq0ab3g4